dc.contributor.author |
Aoun E.G. |
dc.contributor.author |
Musallam K.M. |
dc.contributor.author |
Uthman I. |
dc.contributor.author |
Beydoun A. |
dc.contributor.author |
El-Hajj T. |
dc.contributor.author |
Taher A.T. |
dc.contributor.editor |
|
dc.date |
Jul-2009 |
dc.date.accessioned |
2017-10-05T15:41:02Z |
dc.date.available |
2017-10-05T15:41:02Z |
dc.date.issued |
2009 |
dc.identifier |
10.1177/0961203309103057 |
dc.identifier.isbn |
|
dc.identifier.issn |
09612033 |
dc.identifier.uri |
http://hdl.handle.net/10938/17787 |
dc.description.abstract |
Familial Mediterranean fever (FMF) was recently associated with a hypercoagulable state. However, clinically overt thrombosis remains a rare event limited to patients with other predisposing factors. We herein present a child with FMF who experienced a stroke. An extensive thrombophilia work-up revealed multiple inherited and acquired risk factors. In areas with high prevalence of prothrombotic mutations and in children who are products of consanguineous marriages, early screening for concurrent thrombotic risk factors is warranted; as this may help design an optimal management plan and prevent unfavourable outcomes. © The Author(s), 2009. |
dc.format.extent |
|
dc.format.extent |
Pages: (845-847) |
dc.language |
English |
dc.publisher |
LONDON |
dc.relation.ispartof |
Publication Name: Lupus; Publication Year: 2009; Volume: 18; no. 9; Pages: (845-847); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors |
dc.type |
Article |
dc.contributor.affiliation |
Aoun, E.G., Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh 1107 2020, Beirut, Lebanon |
dc.contributor.affiliation |
Musallam, K.M., Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh 1107 2020, Beirut, Lebanon |
dc.contributor.affiliation |
Uthman, I., Division of Rheumatology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Beydoun, A., Division of Neurology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
El-Hajj, T., Division of Neurology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Taher, A.T., Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh 1107 2020, Beirut, Lebanon |
dc.contributor.authorAddress |
Taher, A.T.; Department of Medicine, Hematology-Oncology Division, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El-Solh 1107 2020, Beirut, Lebanon; email: ataher@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Rheumatology; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
Rheumatology |
dc.contributor.authorEmail |
ataher@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Aoun, EG |
dc.contributor.authorInitials |
Musallam, KM |
dc.contributor.authorInitials |
Uthman, I |
dc.contributor.authorInitials |
Beydoun, A |
dc.contributor.authorInitials |
El-Hajj, T |
dc.contributor.authorInitials |
Taher, AT |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Taher, AT (reprint author), American Univ, Beirut Med Ctr, Dept Internal Med, Div Hematol Oncol, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Aksu G, 2007, CLIN RHEUMATOL, V26, P366, DOI 10.1007-s10067-006-0334-y; Andrew M, 1997, THROMB HAEMOSTASIS, V78, P715; Duran R, 2005, CLIN APPL THROMB-HEM, V11, P83, DOI 10.1177-107602960501100110; El-Shanti H, 2006, LANCET, V367, P1016, DOI 10.1016-S0140-6736(06)68430-4; Grabowski EF, 2007, SEMIN PERINATOL, V31, P243, DOI 10.1053-j.semperi.2007.06.001; Kenet G, 2000, STROKE, V31, P1283; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097-00008480-200112000-00002; Nowak-Gottl U, 1999, BLOOD, V94, P3678; SCHOENBERG BS, 1978, NEUROLOGY, V28, P763; Taher A, 2001, THROMB HAEMOSTASIS, V86, P723 |
dc.description.citedCount |
7 |
dc.description.citedTotWOSCount |
5 |
dc.description.citedWOSCount |
5 |
dc.format.extentCount |
3 |
dc.identifier.articleNo |
|
dc.identifier.coden |
LUPUE |
dc.identifier.pubmedID |
19578111 |
dc.identifier.scopusID |
67650616267 |
dc.identifier.url |
|
dc.publisher.address |
1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Lupus |
dc.relation.ispartOfIssue |
9 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Lupus |
dc.relation.ispartofPubTitleAbbr |
Lupus |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
18 |
dc.source.ID |
WOS:000267649900012 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Childhood |
dc.subject.otherAuthKeyword |
Familial mediterranean fever |
dc.subject.otherAuthKeyword |
Stroke |
dc.subject.otherAuthKeyword |
Thrombophilia |
dc.subject.otherChemCAS |
5,10 methylenetetrahydrofolate reductase (FADH2), 9028-69-7 |
dc.subject.otherChemCAS |
C reactive protein, 9007-41-4 |
dc.subject.otherChemCAS |
colchicine, 64-86-8 |
dc.subject.otherChemCAS |
immunoglobulin, 9007-83-4 |
dc.subject.otherChemCAS |
Factor V, 9001-24-5 |
dc.subject.otherChemCAS |
Methylenetetrahydrofolate Reductase (NADPH2), 1.5.1.20 |
dc.subject.otherChemCAS |
factor V Leiden |
dc.subject.otherIndex |
5,10 methylenetetrahydrofolate reductase (FADH2) |
dc.subject.otherIndex |
anticoagulant agent |
dc.subject.otherIndex |
antinuclear antibody |
dc.subject.otherIndex |
blood clotting factor 5 Leiden |
dc.subject.otherIndex |
C reactive protein |
dc.subject.otherIndex |
colchicine |
dc.subject.otherIndex |
immunoglobulin |
dc.subject.otherIndex |
lupus anticoagulant |
dc.subject.otherIndex |
steroid |
dc.subject.otherIndex |
adolescent |
dc.subject.otherIndex |
anamnesis |
dc.subject.otherIndex |
antibody detection |
dc.subject.otherIndex |
antiphospholipid syndrome |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
case report |
dc.subject.otherIndex |
cerebrovascular accident |
dc.subject.otherIndex |
diagnostic error |
dc.subject.otherIndex |
diplopia |
dc.subject.otherIndex |
dysarthria |
dc.subject.otherIndex |
dysphonia |
dc.subject.otherIndex |
familial Mediterranean fever |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
gait |
dc.subject.otherIndex |
gene mutation |
dc.subject.otherIndex |
Guillain Barre syndrome |
dc.subject.otherIndex |
heterozygosity |
dc.subject.otherIndex |
homozygosity |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
laboratory test |
dc.subject.otherIndex |
microalbuminuria |
dc.subject.otherIndex |
nuclear magnetic resonance imaging |
dc.subject.otherIndex |
nystagmus |
dc.subject.otherIndex |
pain |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
protein blood level |
dc.subject.otherIndex |
risk factor |
dc.subject.otherIndex |
sensory dysfunction |
dc.subject.otherIndex |
stroke |
dc.subject.otherIndex |
temperature sense |
dc.subject.otherIndex |
thrombophilia |
dc.subject.otherIndex |
thrombosis |
dc.subject.otherIndex |
Adolescent |
dc.subject.otherIndex |
Consanguinity |
dc.subject.otherIndex |
Factor V |
dc.subject.otherIndex |
Familial Mediterranean Fever |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Methylenetetrahydrofolate Reductase (NADPH2) |
dc.subject.otherIndex |
Mutation |
dc.subject.otherIndex |
Risk Factors |
dc.subject.otherIndex |
Stroke |
dc.subject.otherKeywordPlus |
FACTOR-V-LEIDEN |
dc.subject.otherKeywordPlus |
ISCHEMIC-STROKE |
dc.subject.otherKeywordPlus |
PERINATAL STROKE |
dc.subject.otherKeywordPlus |
MUTATION |
dc.subject.otherWOS |
Rheumatology |